Syndicate This week's upcoming IPO's and secondary offerings

Week of June 1 to June 5, 2024

This Week's Priced Deals

06/01 - Monday

Symbol

Issuer

Type

Price

Managers

ADAP

Adaptimmune
Adaptimmune
Secondary
Priced: $11.00
20M
TD Cowen & Leerink,...

Pricing after close
Deal analysis and details

Managers: TD Cowen & Leerink, Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ALLO

Allogene Therapeutics
Allogene Therapeutics
Secondary
Priced: $47.00
11.7M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Jefferies & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DGLY

Digital Ally
Digital Ally
Secondary
Priced: $1.65
3.1M
Aegis

Pricing after close

Managers: Aegis

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GH

Guardant Health
Guardant Health
Spot Secondary
Priced: $84.00
11.5M
JPMorgan

Pricing after close
Deal analysis and details

Managers: JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
INVH

Invitation Homes
Invitation Homes
Spot Secondary
Priced: $27.25
14.5M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Goldman Sachs & Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KLDO

Kaleido Biosciences
Kaleido Biosciences
Spot Secondary
Priced: $7.50
4.75M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
QTS

QTS Realty Trust
QTS Realty Trust
Spot Secondary
Priced: $64.90
4.4M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Morgan Stanley, Goldman Sachs, Jefferies & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RGA

Reinsurance Group
Reinsurance Group
Spot Secondary
Priced: $81.00
6.173M
Barclays & JPMorgan

Pricing after close
Deal analysis and details

Managers: Barclays & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

06/02 - Tuesday

Symbol

Issuer

Type

Price

Managers

SPCE

Virgin Galactic
Virgin Galactic
Block Trade
Priced: $15.20
5.6M
Credit Suisse

Pricing after close
Deal analysis and details

Managers: Credit Suisse

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PLRX

Pliant Therapeutics
Pliant Therapeutics
IPO
Priced: $16.00
9M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, TD Cowen & Piper Sandler, Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
WMG

Warner Music
Warner Music
IPO
Priced: $25.00
75M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley, Credit Suisse & Goldman Sachs, BofA, Citi & JPMorgan, Barclays, Evercore ISI, Guggenheim, Macquarie, Nomura, RBC Capital, Truist, CIBC, HSBC, SG Americas, Societe Generale, LionTree, Raine, AmeriVet, Bancroft, Loop Capital, Ramirez, Siebert, Telsey Tigress

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DT

Dynatrace
Dynatrace
Secondary
Priced: $35.00
30M
Goldman Sachs & JPMorgan

Pricing after close
Deal analysis and details

Managers: Goldman Sachs & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NTLA

Intellia Therapeutics
Intellia Therapeutics
Secondary
Priced: $18.25
5.48M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Jefferies & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OSUR

OraSure
OraSure
Secondary
Priced: $11.00
8M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Citi & Evercore ISI, UBS, Raymond James

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ARCE

Arco Platform
Arco Platform
Spot Secondary
Priced: $47.70
5.56M
Goldman Sachs & Itau BBA

Pricing after close
Deal analysis and details

Managers: Goldman Sachs & Itau BBA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EVFM

Evofem
Evofem
Spot Secondary
Priced: $3.50
28.5M
Morgan Stanley & Piper Sandler

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HLNE

Hamilton Lane
Hamilton Lane
Spot Secondary
Priced: $70.85
2.995M
JPMorgan & Goldman Sachs

Pricing after close
Deal analysis and details

Managers: JPMorgan & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RNR

RenaissanceRe
RenaissanceRe
Spot Secondary
Priced: $166.00
5.5M
Morgan Stanley & Goldman Sachs

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

06/03 - Wednesday

Symbol

Issuer

Type

Price

Managers

ZI

ZoomInfo
ZoomInfo
IPO
Priced: $21.00
44.5M
JPMorgan & Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan & Morgan Stanley, Barclays & Credit Suisse, BofA, Deutsche Bank, RBC Capital, USBW, Wells Fargo, Canaccord, JMP Securities, Mizuho, Piper Sandler, Raymond James, Stifel, Truist

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CCC

Clarivate Analytics
Clarivate Analytics
Secondary
Priced: $22.50
48M
Citi & Goldman Sachs

Pricing after close
Deal analysis and details

Managers: Citi & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
COE

China Online Education
China Online Education
Secondary
Priced: $19.00
1M
Morgan Stanley & Needham

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GLUU

Glu Mobile
Glu Mobile
Secondary
Priced: $9.25
15M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, Morgan Stanley & UBS, TD Cowen, Wedbush, Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
INUV

Inuvo
Inuvo
Secondary
Priced: $.45
12.222M
Alliance Global Partners

Pricing after close

Managers: Alliance Global Partners

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
WERN

Werner
Werner
Secondary
Priced: $41.00
12.846M
Morgan Stanley

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ALRN

Aileron Therapeutics
Aileron Therapeutics
Spot Secondary
Priced: $1.10
9.091M
William Blair

Pricing after close

Managers: William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NMIH

NMI Holdings
NMI Holdings
Spot Secondary
Priced: $14.50
13.8M
JPMorgan & Goldman Sachs

Pricing after close
Deal analysis and details

Managers: JPMorgan & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TWST

Twist Bioscience
Twist Bioscience
Spot Secondary
Priced: $33.00

JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, TD Cowen & Evercore ISI, Baird

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

06/04 - Thursday

Symbol

Issuer

Type

Price

Managers

AMTI

Applied Molecular Transport
Applied Molecular Transport
IPO
Priced: $14.00
11M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, Jefferies & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CALT

Calliditas Therapeutics
Calliditas Therapeutics
IPO
Priced: $19.50
9.2M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Jefferies & Stifel, Carnegie

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DADA

Dada Nexus
Dada Nexus
IPO
Priced: $16.00
20M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, BofA & Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FOUR

Shift4 Payments
Shift4 Payments
IPO
Priced: $23.00
15M
Citi,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Citi, Credit Suisse & Goldman Sachs, BofA, Morgan Stanley, RBC Capital, Evercore ISI, Raymond James, Truist, Wolfe Research, Citizens Capital, Scotia, TD Securities, Telsey Advisory

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LEGN

Legend Biotech
Legend Biotech
IPO
Priced: $23.00
18.425M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley, JPMorgan & Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AUDC

AudioCodes
AudioCodes
Secondary
Priced: $35.00
2.6M
BofA & Citi,...

Pricing after close
Deal analysis and details

Managers: BofA & Citi, Barclays, Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GLOB

Globant
Globant
Secondary
Priced: $135.00
2M
JPMorgan,...

Pricing after close

Managers: JPMorgan, Goldman Sachs & Citi

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MNLO

Menlo Therapeutics
Menlo Therapeutics
Spot Secondary
Priced: $1.85
27.1M
TD Cowen & Piper Sandler,...

Pricing after close

Managers: TD Cowen & Piper Sandler, LifeSci Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SONM

Sonim
Sonim
Spot Secondary
Priced: $.75
32M
Oppenheimer & Lake Street

Pricing after close
Deal analysis and details

Managers: Oppenheimer & Lake Street

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access